ROZH PHARMA AS
5259 HJELLESTAD
Return on Equity
93,04Â %
Current Ratio
1,46
Debt-to-Equity Ratio
4,46
| Key figures (NOK) | 2022 |
|---|---|
| Revenue | 3Â 901Â 000 |
| Net Income | 321Â 000 |
| Total Assets | 4Â 933Â 000 |
| Total Equity | 345Â 000 |
| Income (NOK) | 2022 |
|---|---|
| Revenue | 3Â 901Â 000 |
| Expenditure | 3Â 456Â 000 |
| Operating Profit | 446Â 000 |
| Financial Income | 0 |
| Financial Costs | 36Â 000 |
| Financial Balance | −36 000 |
| Earnings Before Tax | 409Â 000 |
| Tax | 89Â 000 |
| Net Income | 321Â 000 |
| Balance (NOK) | 2022 |
|---|---|
| Total Fixed Assets | 484Â 000 |
| Total Current Assets | 4Â 448Â 000 |
| Total Assets | 4Â 933Â 000 |
| Total Retained Equity | 321Â 000 |
| Total Equity | 345Â 000 |
| Total Long-Term Debt | 1Â 539Â 000 |
| Total Current Debt | 3Â 049Â 000 |
| Total Equity and Debt | 4Â 933Â 000 |
| Cash flow (NOK) | 2022 |
|---|---|
| Sales Income | 3Â 900Â 000 |
| Other Income | 1Â 000 |
| Revenue | 3Â 901Â 000 |
| Cost of Goods Sold | 2Â 651Â 000 |
| Salary Costs | 527Â 000 |
| Depreciation | 16Â 000 |
| Impairment | 0 |
| Expenditure | 3Â 456Â 000 |
| Operating Profit | 446Â 000 |
| Financial Income | 0 |
| Financial Costs | 36Â 000 |
| Financial Balance | −36 000 |
| Dividends | 0 |
| Net Income | 321Â 000 |
| Balance details (NOK) | 2022 |
|---|---|
| Goodwill | 0 |
| Total Intangible Assets | 0 |
| Real Eastate | 0 |
| Machinery and Plant Facilities | 0 |
| Fixtures | 484Â 000 |
| Total Tangible Assets | 484Â 000 |
| Total Fiancial Fixed Assets | 0 |
| Total Fixed Assets | 484Â 000 |
| Stock | 2Â 024Â 000 |
| Total Investments | 0 |
| Cash, Bank | 1Â 833Â 000 |
| Total Current Assets | 4Â 448Â 000 |
| Total Assets | 4Â 933Â 000 |
| Total Equity | 345Â 000 |
| Short-Term Group Debt | 0 |
| Total Long-Term Debt | 1Â 539Â 000 |
| Creditors | 1Â 312Â 000 |
| Unpaid Taxes | 210Â 000 |
| Dividends | 0 |
| Other Current Debt | 1Â 457Â 000 |
| Total Current Debt | 3Â 049Â 000 |
| Total Equity and Debt | 4Â 933Â 000 |
| Financial indicators | 2022 |
|---|---|
| Return on Equity | 93,04Â % |
| Debt-to-Equity Ratio | 4,46 |
| Operating Profit Margin | 11,43Â % |
| Current Ratio | 1,46 |
| Quick Ratio | 4,34 |
| Equity Ratio | 0,07 |
| Gross Profit Margin | 32,04Â % |
Rotate your device to see the full table